AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Education

Gain a succinct overview of specific topics relating to every day practice with our wide range of education modules and advanced courses; quick and easy to complete anytime, anywhere. You will receive a certificate for completing any of these education activities. CPD points are also available. Our 40-point sessions provide the opportunity to develop indepth knowledge, skills, behaviour and attitudes in a range of therapeutic areas.

T2D injectables: 2. Intensifying to first injectable therapy in patients with ASCVD risk

In this education module, the participant will work through a case study of a type 2 diabetes patient with ASCVD risk factors. The case study uses the decision cycle from the ADA/EASD consensus guidelines for T2D, and features expert video commentary. The module also discusses patient-related concerns leading to clinical inertia, including useful management decisions when faced with this issue.

T2D injectables: 3. Intensifying to first injectable therapy in patients with established ASCVD

This education module takes a case-study based look at the management of a type 2 diabetes patient with established ASCVD. Featuring expert video commentary, participants will use the decision cycle from the ADA/EASD consensus guidelines for T2D to work through a hypothetical case study. This module also discusses GP-related causes of clinical inertia, as well as additional patient factors such as obesity, low health literacy and diabetes distress.

Rethinking first injectable therapies in type 2 diabetes: A practical approach

This accredited learning module explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy. The activity works through 3 in-depth case-studies: a patient with uncomplicated T2D, a patient with ASCVD risk, and a patient with established ASCVD.

Haemochromatosis: 2. Is it really haemochromatosis? Diagnosis and misdiagnosis

This module provides an overview of hereditary haemochromatosis and the symptoms of iron overload. Participants will gain an understanding of how to interpret iron study results, and how to determine when genetic testing is warranted. The module also covers how to access the therapeutic venesection service offered by the Australian Red Cross Blood Service.

Haemochromatosis: 3. Therapeutic venesection for haemochromatosis

In this module, participants will learn about appropriate induction and maintenance venesection schedules for patients with hereditary haemochromatosis, as well as circumstances that warrant referral to a specialist. Participants will also learn how to access the Australian Red Cross Blood Service (ARCBS) High Ferritin app, and how to use it to screen patients for their eligibility to access therapeutic venesection. The module also looks at how to access local alternatives to the ARCBS therapeutic venesection service.

Pages